•
Dec 31, 2016

CRISPR Therapeutics Q4 2016 Earnings Report

Total Revenue
$2.34M
Previous year: $247K
+849.0%
EPS
$0.43
Previous year: -$0.419
-202.5%
Gross Profit
-$13.2M
Previous year: -$5.93M
+123.2%
Cash and Equivalents
$316M
Free Cash Flow
-$53.1M
Total Assets
$345M

CRISPR Therapeutics

CRISPR Therapeutics